Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6520905 | 0.90 | HCAR2 (0.49) | L3MBTL1MAPTKMT2AHCAR2GAA | |
| SCHEMBL6516502 | 0.81 | MAPT (0.52) | L3MBTL1MAPTKMT2AHCAR2MEN1 | |
| SCHEMBL6514405 | 0.81 | NPC1 (0.60) | TDP1L3MBTL1MAPTKMT2AMEN1 | |
| SCHEMBL6516612 | 0.78 | LMNA (0.52) | TDP1L3MBTL1MAPTKMT2AGAA | |
| SCHEMBL6516054 | 0.78 | NPC1 (0.60) | TDP1L3MBTL1MAPTKMT2AMEN1 | |
| SCHEMBL6523619 | 0.78 | HCAR2 (0.54) | TDP1MAPTKMT2AHCAR2MEN1 | |
| SCHEMBL789755 | 0.78 | SMN1; SMN2 (0.60) | TDP1L3MBTL1KMT2ACNR1CNR2 | |
| SCHEMBL6518196 | 0.77 | KMT2A (0.46) | TDP1L3MBTL1KMT2ACNR1CNR2 | |
| SCHEMBL8998922 | 0.75 | LMNA (0.64) | TDP1L3MBTL1KMT2AGAAMEN1 | |
| SCHEMBL8998925 | 0.75 | LMNA (0.64) | TDP1L3MBTL1KMT2AGAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | TDP1 1789/4885L3MBTL1 1615/4885MAPT 3438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.